All jn-vaccines.org web sites are under construction for review & edit for accuracy
 
 Home Global Health   Vaccines Patents   Diagnostics  Contact us 

Vaccine Products

SYMPTOMS OF MENINGITIS

The common signs and symptoms of meningitis and septicemia. Others can include rapid breathing, diarrhea, stomach cramps and a rash that does not fade under pressure. In babies, check if the soft spot (fontanelle) on the top of the head is tense or bulging.

BABIES AND TODDLERS

High fever vomiting, diarrhea

High pitched moaning, cry

Blank, Pale, blotchy complexion

Baby dislike being handled

Difficult to wake or lethargic

CHILDREN & ADULTS

High fever, vomiting, diarrhea

Severe headache

Neck stiffness

Joint or muscle pains

Dislike of bright lights

Drowsiness

Fits

 

   VACCINE PRODUCTS for Infants, Children & Adults

 

BACTERIAL VACCINES:
• B.C.G. Vaccine
• Diphtheria and Tetanus Vaccine (Adult) &  (Pediatric)
• Diphtheria, Tetanus, and Pertussis Vaccine (DTP Vaccine)
VIRAL VACCINES:  
DTP+Hb
• Hepatitis B
• Polio +Hb
• Yellow fever  
• Measles, Mumps and Rubella (MMR) Vaccine

 

 

MENINGOCOCCAL MENINGITIS VACCINE 

 

Meningitis vaccines meet the requirements established by the World Health Organization and U.S. and European Pharmacopoeia.

 

 

 

      

 

 

 

 

Meningococcal meningitis A/C/Y/W-135/X  Polysaccharide Vaccine

NmVac4-A/C/Y/W-135™ PATENT PENDING

(Serotypes A,C,Y,W-135) for Adults and Children

Plain polysaccharide vaccine to protect from Meningococcal meningitis serogroups A/C/Y/W-135.  (10/50-dose vials) for adults and children - 18-moths protective immunity

PRODUCT BROCHUREAdobe Acrobat [pdf] file

Meningococcal Vaccine Products for Africa and Hajji

Disclaimer meningococcal meningitis vaccines: The corporation cannot commit on availability of these products because of uncertain on regulatory documentation for export approval for either finished product or for raw material.  A possible availability of this product  is in 2010. Posted: JULY, 2008

       

 

 

 

 

 

 

Meningococcal meningitis A/C/Y/W-135/X - DT Conjugate Vaccine

NmVac4-A/C/Y/W-135 DT™ (Serotypes A,C,Y,W-135 Diphtheria toxoid conjugate) for infants and children < 5    PATENT PENDING

 

Diphtheria conjugated polysaccharide vaccine to protect from Meningococcal  meningitis serogroups A/C/Y/W-135 DT conjugate vaccine for infants, children and adults - 3 years protective immunity

 
Disclaimer: This product is still in Research and Development

 

       

 

 

 

 

 Meningococcal meningitis A+C Vaccine  (Trading-in)

(Serotypes A+C vaccine) for Adults and Children

ITS NOT A JN PRODUCT 

Plain polysaccharide vaccine to protect from Neisseria meningitis serogroups A and C  (10-dose vials) call for volume discount and registration documents.

PRODUCT BROCHUREAdobe Acrobat [pdf] file

PLEASE e-MAILto resolve back orders

September =                   ; December:        

Stock =  1,500,000 doses e-MAIL

     

 

(Orders strictly accepted from Africa, South America, South East Asia, and Middle East)  - not for sale in the United States.

 

©1998-2005 JN International, Inc. All rights reserved